This year the event program is dedicated to the discussion of topical issues of quality at all stages of the drug life cycle and consistency of approaches to adequate quality.

Vikram Punia, the President of the Group of Companies, has greeted the participants and guests of the conference and noted:

“As you know, we are involved in the pharmaceutical manufacture. Quality is the key word in this field. There can be no compromise here. Quality is defined and assessed by certain standards. These are the standards we will be discussing at the conference. I would like to take this opportunity to invite you to visit one of the company’s flagship plants located in Irkutsk”.

Natalya Malykh, Vice President for Business Development, Pharmasyntez, has spoken at plenary meeting “International Interaction in Good Practices in Modern Geopolitical Environment” and has taken part in panel meeting “The Unifying Role of GxP Practices in Changing Reality”.

During the events industry experts and Russian largest full-cycle pharmaceutical manufacturers have shared their experience of international cooperation on regulatory issues, discussed mechanisms to support developing regulatory systems and the production of innovative and high-tech medicines. Particular attention has been paid to pressing issues of good preclinical and clinical practice, the specifics of reference standard circulation and testing during the introduction into civil circulation.

Record of the first day of the conference is available on website https://gosgmp.ru/translyatsiya/ Code to view: tbervhwh

On September 8, a comprehensive workshop session on good manufacturing practices and conduction of GMP inspections will take place. Join the live stream.